Obesity News

Findings from a case series study revealed that 83% of 30 dietary supplements that were marketed online for weight loss had inaccurate ingredient labels.

BOSTON — Life’s Essential 8, a campaign led by the American Heart Association, is an assortment of interventions “we can all follow” and “associated with much better outcomes,” Clyde W. Yancy, MD, MSc, MACP, MACC, FAHA, FHFSA, said.

BOSTON — Emerging data on the cardiovascular benefits of GLP-1 receptor agonists indicate that these agents could transform cardiovascular care, much like statins did 30 years ago, Clyde W. Yancy, MD, MSc, MACP, MACC, FAHA, FHFSA, said.

BOSTON — Cardiovascular-kidney-metabolic syndrome, or CKM, is a new term endorsed by the American Heart Association that reflects the interplay of metabolic and renal conditions that drive the risk for CVD.

BOSTON — A “laundry list of new trials” in cardiovascular medicine has led to “a decided portfolio of new ways of thinking, new interventions and a new potential to modify the natural history of CVD,” an expert said.

Acrochordons, also known as skin tags or fibroepithelial polyps, are correlated with metabolic disease and obesity in pediatric patients, according to a study.

Adults who initiate a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those prescribed a DPP-IV inhibitor or an SGLT2 inhibitor, according to study findings published in The BMJ.

DENVER — Losing weight is good for patients’ wallets as well as their health, according to a presenter at the Obesity Medicine Association’s annual conference.

Dietary supplements marketed online to promote weight loss commonly have inaccurate labels and may include unsafe ingredients for the public to use, according to findings published in JAMA Network Open.

Adults who had not used a previous obesity medication lost more weight after receiving semaglutide than those who did, according to a study published in Diabetes, Obesity and Metabolism.